• Vault Minerals receives superior $5.6bn merger proposal from Genesis Minerals

    Businesswoman holds hand out to shake.

    The Vault Minerals Ltd (ASX: VAU) share price is in focus today after the company received a superior merger proposal from Genesis Minerals Ltd (ASX: GMD), valuing Vault at $5.6 billion and offering a 15.7% premium to its previous closing price.

    What did Vault Minerals report?

    • Received an unsolicited binding merger proposal from Genesis Minerals 
    • Proposed consideration: 0.7629 Genesis shares plus $0.475 in cash for every Vault share
    • Total implied Vault equity value: $5.6 billion, or $5.274 per share
    • The offer represents a 15.7% premium to Vault’s last closing price
    • Mix and match facility available for shareholders to elect cash or scrip, within set limits

    What else do investors need to know?

    The Vault board has unanimously determined that the Genesis proposal is a “Vault Superior Proposal” under its existing agreement with Regis Resources. As a result, Vault has notified Regis and triggered a five business day matching right period, expiring at 11:59pm (AWST) on 10 July 2026. During this time, Regis may choose to make a matching or superior proposal to Genesis’s offer.

    The Genesis offer is not subject to finance or due diligence and is otherwise on similar terms to the proposed Regis merger, including conditions precedent and break fees. Vault shareholders are advised that no action is required from them at this stage while the matching right period is ongoing.

    What’s next for Vault Minerals?

    Vault will await any response from Regis Resources within the five business day period before making further announcements. The outcome of this process will determine whether Vault proceeds with the Genesis proposal or the existing Regis scheme.

    The company has reiterated that until the matching right period concludes, it is unable to comment further on the Genesis proposal. Shareholders are encouraged to stay informed as updates become available.

    Vault Minerals share price snapshot

    Over the past 12 months, Vault Minerals shares have risen 82%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 3% over the same period.

    View Original Announcement

    The post Vault Minerals receives superior $5.6bn merger proposal from Genesis Minerals appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Vault Minerals right now?

    Before you buy Vault Minerals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Vault Minerals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Regis Resources hits top end of FY26 guidance

    Teen standing in a city street smiling and throwing sparkling gold glitter into the air.

    The Regis Resources Ltd (ASX: RRL) share price is in focus today after the company hit the top end of its annual production guidance, with FY26 group gold output reaching 379,000 ounces.

    What did Regis Resources report?

    • FY26 total group gold production: 379koz (top end of guidance, up 12% in Q4 to 101.5koz)
    • $1.21 billion cash and bullion on hand at 30 June 2026, up $692 million over the year
    • Dividend payments for the year: $151 million
    • Tax payments for the year: $156 million
    • Quarterly underlying cash and bullion generated: $284 million (before dividend and tax)

    What else do investors need to know?

    Regis Resources achieved its FY26 gold production target, with strong contributions from both its Duketon and Tropicana operations. Duketon produced 236,000 ounces, while Tropicana contributed 143,100 ounces, both meeting or exceeding their respective guidance ranges. The company expects to be within previous guidance for all key metrics including all-in sustaining costs (AISC), growth capital expenditure, and exploration spending. AISC is anticipated to land towards the higher end of its guidance range. Investors are set to receive more detailed financial results and operational details when Regis releases its full quarterly report and holds a conference call on 24 July 2026.

    What’s next for Regis Resources?

    Looking ahead, Regis will continue to focus on disciplined growth and maintaining strong balance sheet flexibility. The management reaffirmed its commitment to staying within all key guidance ranges as it looks to build on this year’s production success. With robust cash generation and operational stability, investors will be watching closely as Regis moves into FY27, including updates on cost management and any growth initiatives flagged in the July quarterly.

    Regis Resources share price snapshot

    Over the past 12 months, Regis Resources shares have risen 51%, outperforming the S&P/ASX 200 Index (ASX: XJO) which 

    View Original Announcement

    The post Regis Resources hits top end of FY26 guidance appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Regis Resources right now?

    Before you buy Regis Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Regis Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Infratil shares on watch after CDC Data Centres’ valuation climbs

    A woman presenting company news to investors looks back at the camera and smiles.

    The Infratil Ltd (ASX: IFT) share price is on watch after the company revealed a 23.6% quarterly jump in the independent valuation of its CDC Data Centres interest, reaching a midpoint of A$18.5 billion. The uplift was fuelled by rapid growth in CDC’s contracted capacity to over 1GW and a bigger pipeline out to FY40.

    What did Infratil report?

    • CDC’s independent valuation rose by A$3.5 billion during the quarter to a midpoint of A$18.5 billion.
    • Infratil’s 49.72% share in CDC is now valued at A$9,213 million, up from A$7,454 million in March 2026.
    • Contracted capacity at CDC increased to over 1GW, including a new 555MW contract and further expansion in New Zealand.
    • Leasable operating capacity lifted by 90MW to 550MW, with the pipeline to FY40 now 3.9GW, up from 2.6GW.
    • Net debt at CDC increased to A$5,976 million, supporting its accelerated build program.

    What else do investors need to know?

    CDC’s build program is running faster to deliver the surge in contracted capacity expected by FY29, with under-construction leasable capacity doubling this quarter to 810MW. The future pipeline was extended to FY40, adding an extra 1.3GW of future build capacity, particularly targeting Australian markets to meet pressing customer demand. The independent valuation also factored in a 25 basis point increase in the risk-free rate, partly offsetting the positive cashflow momentum. CDC recently issued a A$1 billion hybrid capital bond and received a Moody’s Baa2 (Stable) credit rating, supporting funding diversification.

    What’s next for Infratil?

    Looking ahead, Infratil expects CDC’s growth momentum to continue, with ongoing investment in data centre capacity aimed at supporting new and existing contracts out to FY40. By rolling forward pipeline disclosures and redefining capacity metrics to focus on leasable, revenue-generating potential, Infratil is aiming to match evolving customer needs and capitalise on data centre sector demand. As CDC accelerates expansion across Australia and New Zealand, investors can anticipate regular updates as projects move from planning to operation. Interest rate and funding trends will remain key influences.

    Infratil share price snapshot

    Over the past 12 months, Infratil shares have risen 23%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

    View Original Announcement

    The post Infratil shares on watch after CDC Data Centres’ valuation climbs appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Infratil right now?

    Before you buy Infratil shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Infratil wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • The Howard Hughes Corporation (NYSE:HHC) Just Reported And Analysts Have Been Cutting Their Estimates

  • Results From Oxford University’s Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

  • Alcoa CEO Sees No Certainty a Definitive Recovery Is Coming

  • More consumers show interest in traveling on cruises in the near term: Analyst